The pharma is dipping its toe in the water through the deal to access a vector that 4DMT has used for four different product candidates. The furthest along is 4D-150, which is in phase 1/2 trials ...

In major step toward the clinic, Ring’s human viral vector delivers gene therapy to eyes of mice By Helen Floersh Apr 2, 2024 8:10am Cell & Gene Therapy Flagship Pioneering viral vectors Biotech ...